BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3011859)

  • 1. Expression of the human c-fms proto-oncogene product (colony-stimulating factor-1 receptor) on peripheral blood mononuclear cells and choriocarcinoma cell lines.
    Rettenmier CW; Sacca R; Furman WL; Roussel MF; Holt JT; Nienhuis AW; Stanley ER; Sherr CJ
    J Clin Invest; 1986 Jun; 77(6):1740-6. PubMed ID: 3011859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fms gene and the CSF-1 receptor.
    Sherr CJ; Rettenmier CW
    Cancer Surv; 1986; 5(2):221-32. PubMed ID: 3022923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colony-stimulating factor-1 receptor (c-fms).
    Sherr CJ; Roussel MF; Rettenmier CW
    J Cell Biochem; 1988 Nov; 38(3):179-87. PubMed ID: 2852667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1.
    Sherr CJ; Rettenmier CW; Sacca R; Roussel MF; Look AT; Stanley ER
    Cell; 1985 Jul; 41(3):665-76. PubMed ID: 2408759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific binding of the mononuclear phagocyte colony-stimulating factor CSF-1 to the product of the v-fms oncogene.
    Sacca R; Stanley ER; Sherr CJ; Rettenmier CW
    Proc Natl Acad Sci U S A; 1986 May; 83(10):3331-5. PubMed ID: 3010289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colony-stimulating factor 1-mediated regulation of a chimeric c-fms/v-fms receptor containing the v-fms-encoded tyrosine kinase domain.
    Roussel MF; Downing JR; Ashmun RA; Rettenmier CW; Sherr CJ
    Proc Natl Acad Sci U S A; 1988 Aug; 85(16):5903-7. PubMed ID: 2842754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the CSF-1 receptor gene (C-fms) in cell transformation.
    Sherr CJ
    Leukemia; 1988 Dec; 2(12 Suppl):132S-142S. PubMed ID: 2848991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus.
    Coussens L; Van Beveren C; Smith D; Chen E; Mitchell RL; Isacke CM; Verma IM; Ullrich A
    Nature; 1986 Mar 20-26; 320(6059):277-80. PubMed ID: 2421165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirements for transformation by the fms oncogene product (CSF-1 receptor).
    Rettenmier CW; Roussel MF; Wheeler EF; Sherr CJ
    Princess Takamatsu Symp; 1986; 17():211-8. PubMed ID: 2843495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies to the human CSF-1 receptor (c-fms proto-oncogene product) detect epitopes on normal mononuclear phagocytes and on human myeloid leukemic blast cells.
    Ashmun RA; Look AT; Roberts WM; Roussel MF; Seremetis S; Ohtsuka M; Sherr CJ
    Blood; 1989 Feb; 73(3):827-37. PubMed ID: 2465043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The colony-stimulating factor 1 (CSF-1) receptor (c-fms proto-oncogene product) and its ligand.
    Rettenmier CW; Roussel MF; Sherr CJ
    J Cell Sci Suppl; 1988; 9():27-44. PubMed ID: 2978516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posttranscriptional stabilization of c-fms mRNA by a labile protein during human monocytic differentiation.
    Weber B; Horiguchi J; Luebbers R; Sherman M; Kufe D
    Mol Cell Biol; 1989 Feb; 9(2):769-75. PubMed ID: 2523515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the c-fms proto-oncogene during human monocytic differentiation.
    Sariban E; Mitchell T; Kufe D
    Nature; 1985 Jul 4-10; 316(6023):64-6. PubMed ID: 2409450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the human c-fms gene product and its expression in cells of the monocyte-macrophage lineage.
    Woolford J; Rothwell V; Rohrschneider L
    Mol Cell Biol; 1985 Dec; 5(12):3458-66. PubMed ID: 3018521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of c-fms and CSF-1 RNA by in situ hybridization.
    Wakamiya N; Horiguchi J; Kufe D
    Leukemia; 1987 Jun; 1(6):518-20. PubMed ID: 2444833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformation by the v-fms oncogene product: an analog of the CSF-1 receptor.
    Rettenmier CW; Jackowski S; Rock CO; Roussel MF; Sherr CJ
    J Cell Biochem; 1987 Feb; 33(2):109-15. PubMed ID: 3032997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The v-fms oncogene induces factor independence and tumorigenicity in CSF-1 dependent macrophage cell line.
    Wheeler EF; Rettenmier CW; Look AT; Sherr CJ
    Nature; 1986 Nov 27-Dec 3; 324(6095):377-80. PubMed ID: 3024013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming potential of the c-fms proto-oncogene (CSF-1 receptor).
    Roussel MF; Dull TJ; Rettenmier CW; Ralph P; Ullrich A; Sherr CJ
    Nature; 1987 Feb 5-11; 325(6104):549-52. PubMed ID: 3027579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colony stimulating factor-1 induced growth stimulation of v-fms transformed fibroblasts.
    Lyman SD; Park L; Rohrschneider LR
    Oncogene; 1988 Oct; 3(4):391-5. PubMed ID: 2856249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttranscriptional regulation of colony-stimulating factor-1 (CSF-1) and CSF-1 receptor gene expression during inhibition of phorbol-ester-induced monocytic differentiation by dexamethasone and cyclosporin A: potential involvement of a destabilizing protein.
    Chambers SK; Gilmore-Hebert M; Wang Y; Rodov S; Benz EJ; Kacinski BM
    Exp Hematol; 1993 Sep; 21(10):1328-34. PubMed ID: 8359233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.